Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Parenteral and Enteral Nutrition
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Christensen, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christensen, M. L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The Effect of Dietary Protein Depletion on Hepatic 5-Fluorouracil Metabolism L. E. DAVIS, R. E. LENKINISKI, M. A. SHINKWIN, ET AL CANCER 72:3715-3722, 1993

Michael L. Christensen, PHARMD

The University of Tennessee Memphis Memphis, TN

This study investigated the mechanism of protein depletion and its effect on host toxicity to 5-fluorouracil. The effects of protein malnutrition on the hepatic metabolism of 5-fluorouracil were examined using 19F-nuclear magnetic resonance spectroscopy, pharmacokinetic disposition of 5-fluorouracil, and hepatic dihydropyrimidine dehydrogenase activity. Harlan Sprague-Dawley rats were given 5-fluorouracil (150 mg/kg) by intraperitoneal injection after receiving normal (21.5%) or low (2.5%) protein diets for 19 to 30 days (mean, 25 days). Toxicity was assessed by weight loss, lymphocyte count, and survival. Hepatic fluorine spectra were used to evaluate the time to achieve maximum 5-fluorouracil concentration, apparent hepatic 5-fluorouracil half-life, duration of detectable 5-fluorouracil concentrations, and time to reach peak fluoro-β-alanine concentration (the main 5-fluorouracil degradation product). Parallel experiments determined the pharmacokinetic disposition of 5-fluorouracil and the hepatic dihydropyrimidine dehydrogenase activity.

In the low-protein group, the initial detection of the degradation product fluoro-β-alanine and the mean duration of 5-fluorouracil signal in the liver were significantly prolonged: time to reach peak fluoro-β-alanine (minutes) 62 ± 39 vs 24 ± 12 (p < .05) and apparent 5-fluorouracil half-life (minutes) 96 ± 63 vs 42 ± 22 (p < .001). The 5-fluorouracil clearance and the hepatic dihydropyrimidine dehydrogenase activity were also significantly lower in the low-protein group: 1.8 ± 0.8 L/h/kg vs 7.3 ± 2.1 Llhlkg ( p < .05) and 0.29 ± 0.04 U/mg of protein vs 0.37 ± 0.04 U/mg of protein (p < .05), respectively. Compared with animals fed a normal diet, animals in the low-protein group sustained greater weight loss (g) 36 ± 17 vs 16 ± 17 (p < .05), lower lymphocyte count (mm3) 1767 ± 993 vs 5575 ± 2239 (p < .05), and greater mortality 7 days after 5-fluorouracil (8/9 vs 1/10) ( p < .01).

Journal of Parenteral and Enteral Nutrition, Vol. 19, No. 1, 88-89 (1995)
DOI: 10.1177/014860719501900188
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?